Research: The most important factor in determining the success of a medical device in vivo is the host immune response; however this has not been extensively studied with cardiovascular biomaterials. Additionally, both acute myocardial infarction and chronic cardiomyopathy require treatment modalities to provide mechanical support as well as induce positive tissue remodeling. New devices composed of biologically derived extracellular matrix (ECM) provide options for inducing a favorable host tissue remodeling response for treating cardiovascular indications, but few studies have been done comparing such materials to the most commonly used synthetic materials. My work will evaluate the immune response and tissue remodeling outcomes for several commercially available and novel cardiovascular biomaterials.
Publications:
Conferences: